- Trials with a EudraCT protocol (5,526)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (710)
5,526 result(s) found for: Bone.
Displaying page 1 of 277.
EudraCT Number: 2005-004942-15 | Sponsor Protocol Number: CZOL446EIT14 | Start Date*: 2005-12-15 | |||||||||||
Sponsor Name:NOVARTIS FARMA | |||||||||||||
Full Title: A prospective, randomized, multi-center comparative 2-arm trial on efficacy and safety of zoledronic acid every 3-months vs. every 4 weeks beyond approximately 1 year of treatment with zoledronic... | |||||||||||||
Medical condition: bone metastasis in patients with breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-021755-34 | Sponsor Protocol Number: 2010-021755-34 | Start Date*: 2010-07-22 | |||||||||||||||||||||
Sponsor Name:ISTITUTO NAZIONALE PER LA CURA TUMORI | |||||||||||||||||||||||
Full Title: Phase II study on imatinib in combination with RAD001 in advanced chordoma | |||||||||||||||||||||||
Medical condition: PDGFRB and mTOR (or S6 or 4BP1) positive advanced chordoma | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-018491-24 | Sponsor Protocol Number: 31295 | Start Date*: 2010-07-15 | |||||||||||
Sponsor Name:Vrije Universiteit Medical Center | |||||||||||||
Full Title: Effect of aminobisphosphonates and statins on circulating Vy9Vd2-T cells | |||||||||||||
Medical condition: patients with malignant bone metastases | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-009374-27 | Sponsor Protocol Number: 20080540 | Start Date*: 2009-08-27 | |||||||||||
Sponsor Name:Amgen Inc | |||||||||||||
Full Title: An Open Label, Single Arm, Extension Study to Evaluate the Long Term Safety of Denosumab in the Treatment of Bone Metastases in Subjects with Advanced Cancer or Multiple Myeloma | |||||||||||||
Medical condition: Bone metastases in subjects with advanced cancer or multiple myeloma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000848-65 | Sponsor Protocol Number: 20050244 | Start Date*: 2006-09-01 | |||||||||||
Sponsor Name:Amgen Inc | |||||||||||||
Full Title: A Randomized, Double-Blind, Multicenter Study of Denosumab Compared With Zoledronic Acid (Zometa) in the Treatment of Bone Metastases in Subjects with Advanced Cancer (Excluding Breast and Prostate... | |||||||||||||
Medical condition: Treatment of bone metastases in subjects with advanced cancer (excluding breast and prostate cancer) or multiple myeloma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) ES (Completed) PT (Completed) AT (Completed) NL (Completed) BE (Completed) HU (Completed) GB (Completed) LT (Completed) DE (Completed) SK (Completed) LV (Completed) SE (Completed) IT (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-012189-30 | Sponsor Protocol Number: BC1-09 | Start Date*: 2009-10-30 | |||||||||||
Sponsor Name:Algeta ASA | |||||||||||||
Full Title: An open-label Phase IIa, non-randomised, study of Alpharadin in breast cancer patients with bone dominant disease who are no longer considered suitable for endocrine therapy | |||||||||||||
Medical condition: Breast cancer patients with bone dominant disease who have progressed on endocrine therapy and are no longer considered suitable for further endocrine therapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003549-18 | Sponsor Protocol Number: 004/001 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Cliniques Universitaires SAINT-LUC | |||||||||||||
Full Title: REDUCTION OF BONE MORBIDITY USING AN ORAL BISPHOSPHONATE IN FIBROUS DYSPLASIA OF BONE (PROFIDYS Trial) | |||||||||||||
Medical condition: Fibrous dysplasia •Study I: patients with fibrous dysplasia of bone, with bone pain intensity above 3 on a visual analogical scale from 0 to 10. •Study II: patients with fibrous dysplasia of bone... | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003771-19 | Sponsor Protocol Number: 2019-100 | Start Date*: 2019-11-19 | |||||||||||
Sponsor Name:Aarhus Universitetshospital | |||||||||||||
Full Title: The effect of improved insulin sensitivity on bone turnover markers and bone biomechanical properties in persons with type 2 diabetes mellitus | |||||||||||||
Medical condition: Type 2 diabetes mellitus Diabetic bone disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-006964-48 | Sponsor Protocol Number: 20040215 | Start Date*: 2007-04-13 | |||||||||||
Sponsor Name:Amgen Inc | |||||||||||||
Full Title: An Open-Label, Multi-Center, Phase 2 Safety and Efficacy Study of Denosumab (AMG 162) in Subjects with Recurrent or Unresectable Giant Cell Tumor (GCT) of Bone | |||||||||||||
Medical condition: Giant Cell Tumor (GCT) of bone | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-018044-18 | Sponsor Protocol Number: TaxiumII | Start Date*: 2012-06-22 | ||||||||||||||||
Sponsor Name:Meander MC | ||||||||||||||||||
Full Title: A randomised phase II study of repeated Rhenium-188 HEDP combined with Docetaxel versus Docetaxel alone in castration resistant prostate cancer (CRPC) metastatic to bone’ | ||||||||||||||||||
Medical condition: Men with castration resistant prostate cancer (CRPC) metastatic to bone | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002124-27 | Sponsor Protocol Number: Exa-Bone_1 | Start Date*: 2014-10-28 | |||||||||||
Sponsor Name:Endocrine Research Unit, Odense University Hospital | |||||||||||||
Full Title: GLP-1 Agonist and Bone: Effects of Exenatide on Bone Metabolism | |||||||||||||
Medical condition: bone metabolism | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005327-41 | Sponsor Protocol Number: INT0211 | Start Date*: 2012-04-05 | |||||||||||
Sponsor Name:ISTITUTO NAZIONALE PER LA CURA TUMORI | |||||||||||||
Full Title: Clinical trial randomized and controlled to compare the analgesic efficacy of the association zoledronic acid and 153Sm-lexidronam vs zoledronic acid in patients with skeletal metastases from hormo... | |||||||||||||
Medical condition: Population enrolled in the study is represented by patients bearing advanced prostatic cancer with skeletal metastases and bone pain cancer-associated and treated with analgesic drugs | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-002120-29 | Sponsor Protocol Number: 0822-030 | Start Date*: 2008-08-13 | |||||||||||
Sponsor Name:Merck&Co.,Inc | |||||||||||||
Full Title: A Phase III Study to Assess the Safety, Tolerability, and Efficacy of MK-0822 (Odanacatib) in Prolonging Bone Metastasis-Free Survival in Men with Castration-Resistant Prostate Cancer | |||||||||||||
Medical condition: Prevention of bone metastases in men with prostate cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-002119-42 | Sponsor Protocol Number: 0822-029 | Start Date*: 2008-09-23 | |||||||||||
Sponsor Name:Merck& Co., Inc. | |||||||||||||
Full Title: A Phase III Study to Assess the Tolerability and Efficacy of MK-0822 (Odanacatib) in Reducing the Risk of Bone Metastases and Prolonging Disease-Free Survival in Women with Breast Cancer Spanish t... | |||||||||||||
Medical condition: Prevention of disease recurrence in patients with breast cancer. Spanish indication: Prevención de recurrencia de la enfermedad en pacientes con cáncer de mama | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-001621-94 | Sponsor Protocol Number: 2007-1805 | Start Date*: 2007-08-11 | ||||||||||||||||
Sponsor Name:Lothian Health Board [...] | ||||||||||||||||||
Full Title: Pregabalin Bone Trial. A double-blind randomised controlled trial of pregabalin versus placebo in conjunction with palliative radiotherapy for malignant bone pain. | ||||||||||||||||||
Medical condition: The condition under investigation is cancer induced bone pain (CIBP). This is a major cause of morbidity in patients with cancer and unfortunately standard treatments (including radiotherapy) can b... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-003817-28 | Sponsor Protocol Number: 2014-003817-28 | Start Date*: 2015-09-21 |
Sponsor Name:Region Östergötland | ||
Full Title: Does bisfosfonat preserve the bone volume in transplanted bone in the jaw? | ||
Medical condition: Jaw abnormality | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-003690-25 | Sponsor Protocol Number: PI2012_843_0008 | Start Date*: 2013-01-23 | |||||||||||
Sponsor Name:CHU Amiens | |||||||||||||
Full Title: | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001253-41 | Sponsor Protocol Number: GOIM16002-CABONESTUDY | Start Date*: 2018-03-12 | |||||||||||
Sponsor Name:GRUPPO ONCOLOGICO DELL'ITALIA MERIDIONALE | |||||||||||||
Full Title: Impact of cabazitaxel on metastatic bone disease in patients with castration resistant prostate cancer previously treated with docetaxel | |||||||||||||
Medical condition: 1. Histologically or cytologically confirmed adenocarcinoma of prostate that is resistant to hormone therapy and previously treated with a docetaxel containing regimen. | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001294-18 | Sponsor Protocol Number: CS I-040302/01 | Start Date*: 2007-09-06 | |||||||||||
Sponsor Name:Kuros Biosurgery AG | |||||||||||||
Full Title: A phase 2 randomised, open-label, multi-centre ascending dose study of the efficacy, safety and tolerability of I-040302 versus control injection (bone marrow aspirate or steroids) in children and ... | |||||||||||||
Medical condition: Solitary Bone Cysts | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) CZ (Completed) SK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001458-14 | Sponsor Protocol Number: P130921 | Start Date*: 2015-10-01 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.